These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4231370)

  • 21. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
    Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary testosterone excretion in men after administration of cyproterone and chorionic gonadotropin].
    Winkler K
    Arch Klin Exp Dermatol; 1970; 239(1):65-9. PubMed ID: 4249067
    [No Abstract]   [Full Text] [Related]  

  • 23. Dianette for women with acne.
    Drug Ther Bull; 1990 Feb; 28(4):15-6. PubMed ID: 2151863
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
    Mehrl J
    Fortschr Med; 1988 Aug; 106(25):50-1. PubMed ID: 2971600
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyproterone acetate - ethinylestradiol treatment of hirsutism, acne, seborrhea and alopecia.
    Nardi M; De Aloysio D; Busacchi P; Flamigni C
    Acta Eur Fertil; 1975 Jun; 6(2):153-65. PubMed ID: 127497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The duration of response to norgestimate and ethinyl estradiol in the treatment of acne vulgaris.
    Olson WH; Lippman JS; Robisch DM
    Int J Fertil Womens Med; 1998; 43(6):286-90. PubMed ID: 9920537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of cyproterone acetate in the treatment of acne].
    Piquero Martín J; Acosta H
    Med Cutan Ibero Lat Am; 1982; 10(4):261-6. PubMed ID: 6222232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rational therapy of acne.
    Reisner RM
    Cutis; 1976 Mar; 17(3):527-30. PubMed ID: 138546
    [No Abstract]   [Full Text] [Related]  

  • 29. [Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
    Aydinlik S; Lachnit-Fixson U; Lehnert J
    Fortschr Med; 1986 Jul; 104(27-28):547-50. PubMed ID: 2943651
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic trend in acne associated with the menstrual cycle].
    Cersosimo L; Iannucci D; Consalvo F; Orgiu G
    Clin Ter; 1983 Jun; 105(5):411-4. PubMed ID: 6223780
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV; Korchevaia TA; Kravchenko LIa
    Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of drospirenone/ethinyl estradiol (DRSP/EE) among women with acne reduces acne treatment-related resources.
    Joish VN; Boklage S; Lynen R; Schmidt A; Lin J
    J Med Econ; 2011; 14(6):681-9. PubMed ID: 21892859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.
    Koltun W; Maloney JM; Marr J; Kunz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):171-5. PubMed ID: 21288628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment with the anti-androgens in the female].
    Kaiser E; Loch EG; Winckelmann G; Schröpl F; Dietz M; Hartmann P
    Med Welt; 1976 Sep; 27(39):1836-41. PubMed ID: 135909
    [No Abstract]   [Full Text] [Related]  

  • 35. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy [pproceedings].
    Burton JL; Saihan E
    Br J Dermatol; 1979 Jul; 101 Suppl 17():15-6. PubMed ID: 157155
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of acne and seborrhea using antiandrogens].
    Keller PJ; Fetz A; Schär A; Floersheim Y
    Schweiz Med Wochenschr; 1978 Oct; 108(42):1640-2. PubMed ID: 151916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of low dose oral contraceptives for the management of acne.
    Lemay A; Langley RG
    Skin Therapy Lett; 2002 Dec; 7(10):1-5. PubMed ID: 12658330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in the treatment of acne.
    Kimball AB
    J Reprod Med; 2008 Sep; 53(9 Suppl):742-52. PubMed ID: 18980046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of oral contraceptives on male-pattern alopecia, seborrhoea, acne vulgaris and hirsutism. Anamnestic study on 325 women].
    Hoffmann E; Meiers HG; Hubbes A
    Dtsch Med Wochenschr; 1974 Oct; 99(43):2151-4, 2157. PubMed ID: 4139008
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of hirsutism and acne in women with two combinations of cyproterone acetate and ethinylestradiol.
    Cremoncini C; Vignati E; Libroia A
    Acta Eur Fertil; 1976 Dec; 7(4):299-314. PubMed ID: 140576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.